Key points are not available for this paper at this time.
This multicenter study of the Monopoint reperfusion system for LVO thrombectomy outside of the SUMMIT MAX trial demonstrated a high FPE rate and a low rate of major complications.
Koneru et al. (Tue,) studied this question.